-- 漳州片沢黄製薬（上海証券取引所：600436）の2025年の帰属利益は、2024年の29億8000万元から27%減の21億6000万元に減少した。これは、同社が木曜日に上海証券取引所に提出した書類で明らかになった。 同社の1株当たり利益は、前年の4.93元から3.58元に減少した。 営業収益は前年の108億元から17%減の90億元となった。
Related Articles
Australia
AVITA Medical Names Cary Vance as CEO
AVITA Medical's (RCEL) board appointed Cary Vance as president and chief executive officer, effective immediately after serving as CEO on an interim basis since October, the company said Thursday.The board also named Jan Stern Reed as chairman, with immediate effect, AVITA Medical said.Price: $4.33, Change: $+0.10, Percent Change: +2.36%
$RCEL
Australia
NLIGHT Plans to Expand Operations in Torino, Italy
NLIGHT (LASR) said Thursday it plans to expand its existing facility in Torino, Italy, to meet growing demand for locally assembled directed energy systems.The company said the expansion will enhance its capability to supply high-power laser subsystems and integrated components tailored to regional requirements.The upgraded site will focus on local assembly, testing, and lifecycle support for defense applications in European and Middle Eastern markets, nLIGHT said.Shares of the company were up 3.4% in Thursday trading.Price: $67.15, Change: $+2.18, Percent Change: +3.36%
$LASR
Australia
DoorDash, Lyft Expand Partnership Into Canada
DoorDash (DASH) and Lyft (LYFT) said Thursday they are expanding their partnership into Canada, enhancing the value of DashPass by introducing rideshare savings for members.DashPass is DoorDash's membership program designed to help customers save on everyday purchases, offering free delivery and reduced service fees on eligible orders.The expansion aims to transform DashPass into a broader lifestyle membership and help Lyft reach a new rider base, according to the statement.DashPass members can save on Lyft through upfront discounts on eligible rides, the statement added.Price: $169.50, Change: $+0.16, Percent Change: +0.10%
$DASH$LYFT